GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Consensus Rating of “Moderate Buy” by Analysts

GE HealthCare Technologies Inc. (NASDAQ:GEHC) has earned a consensus rating of “Moderate Buy” from the thirteen ratings firms that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $97.67.

A number of equities research analysts recently commented on the stock. Wells Fargo & Company raised their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. Citigroup boosted their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, February 13th. Finally, Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their price objective for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th.

GE HealthCare Technologies Stock Down 0.2 %

NASDAQ:GEHC opened at $90.67 on Friday. GE HealthCare Technologies has a 1 year low of $74.51 and a 1 year high of $94.80. The stock has a 50-day moving average price of $85.76 and a two-hundred day moving average price of $86.05. The stock has a market cap of $41.46 billion, a price-to-earnings ratio of 20.94, a PEG ratio of 3.19 and a beta of 1.15. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. As a group, equities analysts expect that GE HealthCare Technologies will post 4.68 earnings per share for the current year.

Institutional Investors Weigh In On GE HealthCare Technologies

Large investors have recently made changes to their positions in the stock. LGT Financial Advisors LLC lifted its stake in GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after acquiring an additional 251 shares during the last quarter. CoreFirst Bank & Trust acquired a new stake in GE HealthCare Technologies in the 4th quarter valued at about $25,000. Capital Performance Advisors LLP bought a new position in GE HealthCare Technologies during the third quarter worth about $26,000. Ashton Thomas Securities LLC acquired a new position in GE HealthCare Technologies during the third quarter worth approximately $26,000. Finally, Runnymede Capital Advisors Inc. bought a new stake in GE HealthCare Technologies in the fourth quarter valued at approximately $28,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.